Serum Levels of Lipocalin-2/NGAL, Kidney Injury Molecule 1 (KIM-1), and Interleukin-18 Are Not Related to Risk Predictions for Cardiovascular and Renal Events in Type 2 Diabetes
By: M. Boyanov, M. Nikolov, J. Hristova and D. Bakalov
References
- Ix JH, Shlipak MG. The Promise of Tubule Biomarkers in Kidney Disease: A Review. Am J Kidney Dis, 2021,78(5):719-727.
- Priyadarshini G, Rajappa M. Predictive markers in chronic kidney disease. Clin Chim Acta, 2022, 535:180-186.
- Stopic B, Medic-Brkic B, Savic-Vujovic K, et al. Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease. Dose Response, 2022, 20(3):15593258221127568.
- Romejko K, Markowska M, Niemczyk S. The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). Int J Mol Sci, 2023, 24(13):10470.
- Hu T, Xu Y, Shen Y, et al. Interaction between serum neutrophil gelatinase-associated lipocalin and visceral fat area on cardiovascular health in a cohort of community-based individuals. Clin Chim Acta, 2023, 551:117606.
- Li C, Zhang Z, Peng Y, et al. Plasma neutrophil gelatinase- associated lipocalin levels are associated with the presence and severity of coronary heart disease. PLoS One, 2019, 14(8):e0220841.
- Stopic B, Dragicevic S, Medic-Brkic B, et al. Biomarkers of Uremic Cardiotoxicity. Toxins (Basel), 2021, 13(9):639.
- Yaribeygi H, Atkin SL, Sahebkar A. Interleukin-18 and diabetic nephropathy: A review. J Cell Physiol, 2019, 234(5):5674-5682.
- Cuesta C, Fuentes-Calvo I, Sancho-Martinez SM, et al. Urinary KIM-1 Correlates with the Subclinical Sequelae of Tubular Damage Persisting after the Apparent Functional Recovery from Intrinsic Acute Kidney Injury. Biomedicines, 2022, 10(5):1106.
- Al-Rubeaan K, Nawaz SS, Youssef AM, Al Ghonaim M, Siddiqui K. IL-18, VCAM-1 and P-selectin as early biomarkers in normoalbuminuric Type 2 diabetes patients. Biomark Med, 2019, 13(6):467-478.
- Castillo-Rodriguez E, Fernandez-Prado R, Martin-Cleary C, et al. Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease. Nephron, 2017, 136(4):263-267.
- Ferreira JP, Rossignol P, Bakris G, et al. Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial. Am J Nephrol, 2021, 52(12):969-976.
- Tonkonogi A, Carlsson AC, Helmersson-Karlqvist J, et al. Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes. Ups J Med Sci, 2016, 121 (3):174-8.
- Henry A, Gordillo-Marañón M, Finan C, et al.; HERMES and SCALLOP Consortia. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization. Circulation, 2022, 145(16):1205-1217.
- Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus: Comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabet Med, 2004, 21:238–245.
- Kengne AP. The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes. Cardiovasc J Afr, 2013, 24(9-10): 376-81.
- Holzscheiter L, Beck C, Rutz S, et al. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction. Clin Chem Lab Med, 2014, 52(4):537-46.
- Satirapoj B, Pooluea P, Nata N, Supasyndh O. Urinary bio-markers of tubular injury to predict renal progression and end- stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study. J Diabetes Complications, 2019, 33(9):675-681.
- Mahapatra HS, Kulshreshtha B, Goyal P, et al. Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy. Indian J Med Res, 2022, 156(1):46-55.
- Siddiqi Z, Karoli R, Kaul A, Fatima J, Varshney S, Beg MS. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as early markers of diabetic nephropathy. Ann Afr Med, 2017, 16(3):101-106.
- Liu KD, Yang W, Go AS, et al.; CRIC Study Investigators. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis, 2015, 65(2):267-74.
- Liu H, Wan X, Shi Y, et al. Neutrophil Gelatinase-Associated Lipocalin Contributes to Increased Risk of Cardiovascular Death After Acute Coronary Syndrome. Int J Gen Med, 2021, 14:4887-4895.
- Gaydarski L, Dimitrova IN, Stanchev S, et al. Unraveling the Complex Molecular Interplay and Vascular Adaptive Changes in Hypertension-Induced Kidney Disease. Biomedicines. 2024; 12(8): 1723. doi: 10.3390/biomedicines12081723.
- Nikolova M, Angelova I, Kotseva V, et al. Acute Kidney Injury and Acute Renal Failure in Coronaviral Infection. Acta Medica Bulg, 2022, 49(3): 38-42.
- Gaydarski L, Dimitrova IN, Stanchev S, et al. Unraveling the Complex Molecular Interplay and Vascular Adaptive Changes in Hypertension-Induced Kidney Disease. Bio-medicines, 2025; 13(1):50. https://doi.org/10.3390/biomedicines13010050.
- Stanchev S, Gaydarski L, Dimitrova IN, et al. Renal structural changes and apelin receptor expression in spontaneously hypertensive rats: implications for hypertension-induced kidney injury. Folia Morphologica, 2026; 85: e01726022. https://doi.org/10.5603/fm.100637
DOI: https://doi.org/10.2478/amb-2026-0068 | Journal eISSN: 2719-5384 (formerly 0324-1750) | Journal ISSN: 0324-1750
Language: English
Page range: 17 - 24
Submitted on: Mar 10, 2026
Accepted on: May 5, 2026
Published on: Sep 14, 2026
Published by: Medical University - Sofia
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 M. Boyanov, M. Nikolov, J. Hristova, D. Bakalov, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.